These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5598186)

  • 41. Discovery of parallel pathways of kanamycin biosynthesis allows antibiotic manipulation.
    Park JW; Park SR; Nepal KK; Han AR; Ban YH; Yoo YJ; Kim EJ; Kim EM; Kim D; Sohng JK; Yoon YJ
    Nat Chem Biol; 2011 Oct; 7(11):843-52. PubMed ID: 21983602
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of black strap molasses on kanamycin production by Streptomyces canus.
    Abou-Zeid AA
    Indian J Exp Biol; 1972 Jan; 10(1):77. PubMed ID: 4638015
    [No Abstract]   [Full Text] [Related]  

  • 43. Aph(3')-IIc, an aminoglycoside resistance determinant from Stenotrophomonas maltophilia.
    Okazaki A; Avison MB
    Antimicrob Agents Chemother; 2007 Jan; 51(1):359-60. PubMed ID: 17088477
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The variability of a producer of an antibiotic of the heliomycin type--Actinomyces olivocinereus 11-98--when cultivated under laboratory conditions].
    Vinogradova KA; Vasil'eva LS; Duda VI; Silaev AB; Solov'eva MB
    Antibiotiki; 1974 Mar; 19(3):247-52. PubMed ID: 4463862
    [No Abstract]   [Full Text] [Related]  

  • 45. Enzymatic studies on kanamycin biosynthesis.
    Basak K; Majumdar SK
    Indian J Exp Biol; 1977 Jan; 16(1):57-61. PubMed ID: 615127
    [No Abstract]   [Full Text] [Related]  

  • 46. Alteration of the intestinal microflora following antimicrobial therapy.
    Nichols RL; Condon RE; Gorbach SL
    Rev Surg; 1972; 29(1):53-4. PubMed ID: 5011631
    [No Abstract]   [Full Text] [Related]  

  • 47. The broad-spectrum and the macrolide antibiotics and the ciliary barrier.
    Narasimhan MJ; Ganla VG
    Hindustan Antibiot Bull; 1968; 10(4):295-8. PubMed ID: 5663533
    [No Abstract]   [Full Text] [Related]  

  • 48. [Stability of Act. olivoreticuli--producer of olivomycin--during storage on solid organic substrate].
    Parfenova AI; Sitnikova LV; Gudkova TP; Abramenko IN; Bykov EV
    Antibiotiki; 1968 Nov; 13(11):978-82. PubMed ID: 5712472
    [No Abstract]   [Full Text] [Related]  

  • 49. Use of mutants in the study of aminocyclitol antibiotic biosynthesis and the preparation of the hybrimycin C complex.
    Shier WT; Schaefer PC; Gottlieb D; Rinehart KL
    Biochemistry; 1974 Dec; 13(25):5073-8. PubMed ID: 4433510
    [No Abstract]   [Full Text] [Related]  

  • 50. Impairment of membrane phosphoinositide metabolism by aminoglycoside antibiotics: streptomycin, amikacin, kanamycin, dibekacin, gentamicin and neomycin.
    Marche P; Koutouzov S; Girard A
    J Pharmacol Exp Ther; 1983 Nov; 227(2):415-20. PubMed ID: 6313902
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Elimination of the ability of a kanamycin-producing strain to biosynthesize deoxystreptamine moiety by acriflavine.
    Hotta K; Okami Y; Umezawa H
    J Antibiot (Tokyo); 1977 Dec; 30(12):1146-9. PubMed ID: 599092
    [No Abstract]   [Full Text] [Related]  

  • 52. [Increase of bacterial density at the margin of inhibition areas formed by the antibiotic disks].
    Lorian V; Strauss L
    Hospital (Rio J); 1968 Jul; 74(1):7-9. PubMed ID: 4890309
    [No Abstract]   [Full Text] [Related]  

  • 53. Resistance of Shigella flexneri to antibiotics.
    Slopek S; Tkaczowa A; Mulczyk M
    Arch Immunol Ther Exp (Warsz); 1968; 16(3):354-8. PubMed ID: 5666680
    [No Abstract]   [Full Text] [Related]  

  • 54. Ribostamycin, as an intermediate in the biosynthesis of neomycin.
    Baud H; Betencourt A; Peyre M; Penasse L
    J Antibiot (Tokyo); 1977 Sep; 30(9):720-3. PubMed ID: 924894
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preservation of micro-organisms by drying; a review.
    Morgan CA; Herman N; White PA; Vesey G
    J Microbiol Methods; 2006 Aug; 66(2):183-93. PubMed ID: 16632005
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Antibacterial activity in vitro of ristocetin, kanamycin and farmiglucine].
    Pierangeli L; Vellucci A; Tallarida G; Donati G
    Boll Soc Ital Biol Sper; 1964 Dec; 40(24):1662-3. PubMed ID: 5877895
    [No Abstract]   [Full Text] [Related]  

  • 57. Bacteriological and pharmacological studies on methanesulfonates of kanamycin and fradiomycin (neomycin).
    YAMAZAKI S
    J Antibiot (Tokyo); 1960 Jan; 13():6-18. PubMed ID: 13855447
    [No Abstract]   [Full Text] [Related]  

  • 58. Bacteriological and pharmacological studies on methanesulfonates of kanamycin and fradiomycin (neomycin).
    UMEZAWA H; YAMAZAKI S; MURASE M; NITTA K; HIKIJI T; OSAWA T; TAKEUCHI T
    J Antibiot (Tokyo); 1959 Nov; 12():335-8. PubMed ID: 13855173
    [No Abstract]   [Full Text] [Related]  

  • 59. Field released transgenic papaya effect on soil microbial communities and enzyme activities.
    Wei XD; Zou HL; Chu LM; Liao B; Ye CM; Lan CY
    J Environ Sci (China); 2006; 18(4):734-40. PubMed ID: 17078553
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Production of a new antibacterial antibiotic from a mutated strain of Streptomyces kanamyceticus M27 in submerged fermentation.
    Mukherji B; Chattopadhyay P; Ray L
    Hindustan Antibiot Bull; 2005 Feb-2006 Nov; 47-48(1-4):1-6. PubMed ID: 18697724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.